Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2022

Conditions
Hepatitis B
Trial Locations (1)

Unknown

H. Consorci Sanitari Parc Tauli, Sabadell

Sponsors
All Listed Sponsors
collaborator

Hospital Mutua de Terrassa

OTHER

collaborator

Consorci Sanitari de Terrassa

OTHER

collaborator

Hospital Universitario La Fe

OTHER

collaborator

Germans Trias i Pujol Hospital

OTHER

lead

Corporacion Parc Tauli

OTHER

NCT05446532 - Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes | Biotech Hunter | Biotech Hunter